Indeed, we found that XSECC treatment could phosphorylate/activate AKT and promote the phosphorylation of GSK-3β, thereby enhancing CRMP2 activation in the hippocampus in a rat model of CCH. Here, GSK3B is linked to columnar cell hyperplasia of the breast.